XML 39 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity-Based Compensation
6 Months Ended
Jun. 30, 2014
Share-based Compensation [Abstract]  
Equity-Based Compensation
EQUITY-BASED COMPENSATION
As of June 30, 2014, we had three stock incentive plans under which performance share grants, restricted stock unit (RSU) grants and stock options were outstanding, with approximately 1,082,161 shares authorized for future use under the 2014 Long-Term Incentive Plan.
On May 8, 2014, our board approved changes to our director compensation program. This amendment states that upon a director's separation from the company, all deferred awards will be settled in company stock and no longer settled in cash. This resulted in a reclassification of the related $4.3 million liability to shareholder equity.
As of June 30, 2014, there were 111,306 shares that will be distributed to directors in the future.
The following table details our equity-based compensation expense and director deferred compensation expense for the quarters and six months ended June 30:
 
Quarter Ended   June 30,
 
Six Months Ended   June 30,
 
 
(Dollars in thousands)
2014
 
2013
 
2014
 
2013
Employee equity-based compensation expense:
 
 
 
 
 
 
 
Performance shares
$
961

 
$
891

 
$
1,695

 
$
1,753

Restricted stock units
163

 
138

 
337

 
348

Total employee equity-based compensation expense
$
1,124

 
$
1,029

 
$
2,032

 
$
2,101

 
 
 
 
 
 
 
 
Total tax benefit recognized
$
81

 
$
64

 
$
155

 
$
140

 
 
 
 
 
 
 
 
Director deferred compensation (income) expense
$
427

 
$
(940
)
 
$
(14
)
 
$
350


PERFORMANCE SHARES
The following table presents the key inputs used in the Monte Carlo simulation method to calculate the fair value of the performance share awards in 2014 and 2013, and the resulting fair values:
 
2014
 
2013
Shares granted
87,441

 
83,111

Stock price as of valuation date
$
39.76

 
$
45.31

Risk-free rate
0.72
%
 
0.40
%
Fair value of a performance share
$
45.57

 
$
62.78


The following table summarizes outstanding performance share awards as of June 30, 2014, and changes during the six months ended June 30, 2014:
(Dollars in thousands, except grant date fair value)
Shares
 
Weighted Avg.
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Unvested shares outstanding at January 1
155,814

 
$
48.73

 
 
Granted
87,441

 
45.57

 
 
Forfeited

 


 
 
Unvested shares outstanding at June 30
243,255

 
47.60

 
$
10,071


As of June 30, 2014, there was $6.2 million of unrecognized compensation cost related to unvested performance share awards, which is expected to be recognized over a weighted average period of 1.5 years.




RESTRICTED STOCK UNITS
The following table summarizes outstanding RSU awards as of June 30, 2014, and changes during the six months ended June 30, 2014:
(Dollars in thousands, except grant date fair value)
Shares
 
Weighted Avg.
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Unvested shares outstanding at January 1
37,461

 
$
38.69

 
 
Granted
13,349

 
39.66

 
 
Vested
(4,350
)
 
44.31

 
 
Forfeited

 

 
 
Unvested shares outstanding at June 30
46,460

 
38.44

 
$
1,923


The fair value of each RSU equaled our common share price on the date of grant. The total fair value of RSU awards vested during the six months ended June 30, 2014 was $0.2 million. As of June 30, 2014, there was $0.9 million of total unrecognized compensation cost related to unvested RSU awards, which is expected to be recognized over a weighted average period of 1.4 years.
STOCK OPTIONS
The following table summarizes outstanding stock options as of June 30, 2014, and changes during the six months ended June 30, 2014:
(Dollars in thousands, except exercise prices)
Shares
 
Weighted Avg.
Exercise Price
 
Aggregate
Intrinsic Value
Outstanding at January 1
12,859

 
$
30.92

 
 
Shares exercised
(493
)
 
30.92

 
 
Shares canceled or expired

 

 
 
Outstanding and exercisable at June 30
12,366

 
30.92

 
$
130


The following table summarizes outstanding stock options as of June 30, 2014:
 
Options Outstanding and Exercisable
Exercise Price
Outstanding
 
Weighted Avg.
Remaining
Contractual Life
$30.9204
12,366

 
0.42 years